HomeLPTX • NASDAQ
add
Leap Therapeutics Inc
Previous close
$0.41
Day range
$0.38 - $0.42
Year range
$0.22 - $4.79
Market cap
16.70M USD
Avg Volume
404.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.86M | 8.80% |
Net income | -15.44M | -11.69% |
Net profit margin | — | — |
Earnings per share | -0.37 | 27.45% |
EBITDA | -15.86M | -8.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.71M | -40.44% |
Total assets | 34.88M | -39.83% |
Total liabilities | 14.04M | 32.56% |
Total equity | 20.84M | — |
Shares outstanding | 41.44M | — |
Price to book | 0.82 | — |
Return on assets | -94.41% | — |
Return on capital | -140.85% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.44M | -11.69% |
Cash from operations | -14.48M | 6.68% |
Cash from investing | — | — |
Cash from financing | -61.00K | -310.34% |
Net change in cash | -14.54M | 7.54% |
Free cash flow | -10.21M | 2.62% |
About
Founded
2011
Website
Employees
52
